UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020197
Receipt number R000023326
Scientific Title Extracorporeal shock wave therapy for idiopathic osteonecrosis of the femoral head
Date of disclosure of the study information 2015/12/14
Last modified on 2019/08/26 14:50:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Extracorporeal shock wave therapy for idiopathic osteonecrosis of the femoral head

Acronym

Shock wave for ION

Scientific Title

Extracorporeal shock wave therapy for idiopathic osteonecrosis of the femoral head

Scientific Title:Acronym

Shock wave for ION

Region

Japan


Condition

Condition

idiopathic osteonecrosis of the femoral head

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim was to evaluate the safety and effectiveness of extracorporeal shock wave therapy for idiopathic osteonecrosis of the femoral head.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

progression of femoral head collapse or neurovascular injury at 6 months after intervention

Key secondary outcomes

Japanese Orthopaedic Association hip score, PainDETECT, Visual Analogue Scale, and the final end point of total hip arthroplasty


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Shock wave group was administered with Dornier EposTM (Dornier, Germany), which generates a shock wave by electromagnetic induction.The junctional zone between the osteonecrotic and viable bone of the femoral head was identified radiologically using an image intensifier.Patients were awake without any anesthesia so that they could comment on whether the shock wave was reproducing their hip pain.Shock waves were applied from anterior to posterior with 5000 impulses at a rate of 240 impulses/min.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with ION diagnosed by the classification of the Japanese Ministry of Health, Labor and Welfare, with large necrotic areas of type C1 or C2, with advanced collapse at stage 3B or 4, and undergoing corticosteroid therapy were included.

Key exclusion criteria

Exclusion criteria included patients with skeletal immaturity, previous or current infections, unfavorable skin conditions, or patients with hemorrhagic diathesis.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Junichi
Middle name
Last name Nakamura

Organization

Graduate School of Medicine, Chiba University

Division name

Department of Orthopaedic Surgery

Zip code

260-8670

Address

1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, Japan, 260-8677

TEL

+81-43-226-2117

Email

njonedr@chiba-u.jp


Public contact

Name of contact person

1st name Junichi
Middle name
Last name Nakamura

Organization

Graduate School of Medicine, Chiba University

Division name

Department of Orthopaedic Surgery

Zip code

260-8670

Address

1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, Japan, 260-8677

TEL

+81-43-226-2117

Homepage URL


Email

njonedr@chiba-u.jp


Sponsor or person

Institute

Graduate School of Medicine, Chiba University

Institute

Department

Personal name



Funding Source

Organization

JSPS KAKENHI

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Graduate school of Medicine, Chiba University

Address

1-8-1 Inohana, Chuo-ku, Chiba, Japan

Tel

0432227171

Email

igaku-rinri@office.chiba-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 12 Month 14 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

56

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 12 Month 14 Day

Date of IRB

2015 Year 12 Month 14 Day

Anticipated trial start date

2015 Year 12 Month 14 Day

Last follow-up date

2019 Year 08 Month 26 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 12 Month 14 Day

Last modified on

2019 Year 08 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023326


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name